Inspections, Compliance, Enforcement, and Criminal Investigations


Table of contents


Instructions for planned surveillance activities are found in your Compliance Program Guidance Manual. During your inspectional, investigational, and other activities, be alert to anything which may be new or unusual or interesting from FDA's viewpoint such as:

  1. New firms;
  2. New products;
  3. New production and distribution practices;
  4. New equipment and industrial processes;
  5. Seasonal practices;
  6. Industry trends;
  7. Recent or on-going construction and plans for future expansion;
  8. Proposed products;
  9. New ideas the firm is contemplating;
  10. New products in the development stage;
  11. Activities about a firm's competitor;
  12. Plans for consolidation, mergers, diversification, etc.;
  13. Equipment failures or malfunction possibly affecting other firms, faulty design of equipment, incompatibility of ingredients, faulty process design, equipment manufacturers' recommendations which violate proper manufacturing precautions, health fraud (quackery), etc.
  14. Health Fraud (Quackery) is defined as "the deceptive promotion, advertisement, distribution or sale of articles, intended for human or animal use, which are represented as effective to diagnose, prevent, cure, treat or mitigate disease, or provide a beneficial effect on health, but which have not been scientifically proven safe and effective for such purposes." See CPG: Chapter 1.

Use the FDA-457, Product/Establishment Surveillance Report, to report any of the items listed above. Include any other ideas/observations you may consider worthy of reporting. FDA must keep abreast of new ideas, trends, or contemplated changes in the industries we regulate as well as problems with possible broad impact.

 8.6.2 - FDA 457 PREPARATION

Report product or establishment surveillance on the FDA 457, Product/Establishment Surveillance Report, and submit it to your supervisor. See IOM Exhibit 8-13. Prospective new establishments must be verified for appropriateness before inclusion in the active FEI. See Field Management Directive (FMD) 130.

Complete blocks 1 through 18 and 22 through 26 of the FDA 457 for product surveillance or blocks 1,6, 8 through 10, and 18 through 26 of the FDA 457 for establishment surveillance. Your supervisor or reviewing official will complete blocks 27 through 30. For a human drug firm or product which has not actually entered the market, enter the information in the REMARKS Section.

The following number designations correspond to identically numbered blocks on the FDA 457.

  1. "HOME DISTRICT" - Enter the name of the home dis­trict of the new firm or firm producing the product re­ported. See IOM for definition of home district.
  2. "REPORTING UNIT SYMBOL" - Enter your district sym­bol here (e.g., "ATL-DO", "BLT-DO", "LOS-DO", etc.). If units other than field units report on the form, their mailing symbol goes here.
  3. "CENTRAL FILE NO." - Enter the central file number (CFN) or firm establishment indicator (FEI), if readily available. Otherwise, leave blank.
  4. "J.D./T.A." - Leave blank.
  5. "COUNTY" - Leave blank.
  6. "DATE" - Enter date you prepare the FDA 457.
  7. "PRODUCT CODE" - Enter the 7-character Product Code from the Data Codes Manual.
  8. "OPERATION" - Enter operation code from the Data Codes Manual. For surveillance it is 13.
  9. "PROGRAM ASSIGNMENT CODE" - Enter the Pro­gram/Assignment Code (PAC) from the Data Codes Manual.
  10. "HOURS" - Enter the time spent on this operation, in­cluding time for preparing the report, into FACTS. Report time to the nearest 1/4 hour in fractions, not decimals. Do not report travel time.
  11. "IDENTIFICATION" - Enter the generic name of the product and quote enough of the label to properly identify the item, including the firm name and address.
  12. "MANUFACTURER CONTROL CODES" - Enter all codes, lot numbers, batch codes, etc., found on the containers, labels, wrappers, packages, cases, etc. and indicate whether the number is located on the la­bel, containers, case, etc.
  13. "AMOUNT ON HAND" - List lot size (amount of the products) on hand or available. If count cannot be made, make an estimate and so indicate.
  14. "DATE LOT RECEIVED" - Determine and enter the date the dealer received the lot(s).
  15. "ESTIMATED VALUE" - This is the invoice value of the amount on hand at the time you observed it. Estimate, if not readily available.
  16. "SAMPLE NO(s)" - Enter sample number(s) of any rele­vant samples collected. If no samples are col­lected, enter "None".
  17. "DEALER" - List name and complete address including the ZIP code of dealer who owns or has custody of the product.
  18. "DISTRIBUTOR MANUFACTURER SHIPPER OTHER" - Check applicable box or boxes and list name, complete address, ZIP code and telephone number, including area code.
  19. "ESTABLISHMENT TYPES/INDUSTRY CODES" - Enter up to three establishment types with up to six in­dustry codes each for the establishment.
  20. "ESTABLISHMENT SIZE" - Enter gross dollar value of the annual production of all FDA regulated products made or manipulated in the establishment.
  21. "INFORMATION OBTAINED BY" - Check the applica­ble box to indicate how the FEI information was ob­tained.
  22. "REMARKS" - Enter explanatory information here.
  23. "REPORT PREPARED BY" - Type or print your name and title.
  24. "EMPL NO." - Enter your employee number.
  25. "PC" - Enter your Position Classification code.
  26. "SIGNATURE" - Enter usual signature.
  27. "REPORTING UNIT ACTION" - Your supervisor or re­viewing official completes this section by checking the applicable box.
  28. "NAME OF REVIEWING OFFICIAL" - Typed or printed name of person reviewing the report.
  29. "TITLE" - Title of reviewing official.
  30. "DATE REVIEWED" - The reviewing official enters date report was reviewed.

Complete reverse side of the FDA 457 by checking the appropriate box(s).

 8.6.3 - FDA 457 ROUTING

Submit all FDA 457's to your supervisor for review, as­signment, or routing as indicated:

  1. Human Drug Surveillance - Submit a copy of the FDA 457 to the Center for Drug Evaluation and Research (HFD-323).
  2. Veterinary Drug Surveillance - Submit a copy of the FDA 457 to the Center for Veterinary Medicine, (HFV-236).
  3. Device Surveillance - Submit a copy of the FDA 457 to the Office of Medical Devices (HFZ-331).
  4. Foods Surveillance - Submit a copy of the FDA 457 to the home district.
  5. Tobacco Product Surveillance – Submit a copy of FDA 457 to the Center for Tobacco Products, Office of Compliance and Enforcement
  6. Other Products - Submit a copy of the FDA 457 to the home district.

Back to Top

Table of contents

Page Last Updated: 07/28/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.